Joe A. Mccann serves as Executive at POINT Biopharma Global Inc., where they oversee executive responsibilities. Since joining the company, Joe A. Mccann has executed 5 insider transactions totaling $14.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 22, 2023 involved transacting 3,494,153 shares valued at $0.
Joe A. Mccann currently holds 3,494,153 shares of POINT Biopharma Global Inc. (PNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joe A. Mccann has been a net buyer of PNT stock. They have purchased $14.3K and sold $0 worth of shares.
Joe A. Mccann's most recent insider trade was on Dec 22, 2023, when they sold 3,494,153 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 6, 2023 | PNT | $0 | Gift | 120,000 | $N/A | Discretionary |
| Nov 29, 2022 | PNT | $14.3K | Purchase | 2,160 | $6.64 | Discretionary |
| Jun 30, 2021 | PNT | $0 | Award | 3,614,153 | $N/A | Discretionary |